L. Beaugerie, Épidémiologie des diarrhées et colites aiguës infectieuses en France, Lett Hépato-Gastroentérologue, vol.1, pp.13-16, 2001.

C. Surawicz, R. Haggitt, M. Husseman, and L. Mcfarland, Mucosal biopsy diagnosis of colitis: Acute self-limited colitis and idiopathic inflammatory bowel disease, Gastroenterology, vol.107, issue.3, pp.755-63, 1994.
DOI : 10.1016/0016-5085(94)90124-4

B. Notteghem, J. Salomez, C. Gower-rousseau, R. Marti, M. Lemahieu et al., What is the prognosis in unclassified colitis? Results of a cohort study of 104 patients in the Northern-Pas-de-Calais region, Gastroentérologie Clin Biol, vol.17, pp.811-816, 1993.

F. Tedesco, R. Hardin, R. Harper, and B. Edwards, Infectious colitis endoscopically simulating inflammatory bowel disease: a prospective evaluation, Gastrointestinal Endoscopy, vol.29, issue.3, pp.195-202, 1983.
DOI : 10.1016/S0016-5107(83)72583-6

G. Schumacher, B. Sandstedt, and B. Kollberg, A Prospective Study of First Attacks of Inflammatory Bowel Disease and Infectious Colitis: Clinical Findings and Early Diagnosis, Scandinavian Journal of Gastroenterology, vol.29, issue.3, pp.265-74, 1994.
DOI : 10.3109/00365529409090475

S. Yadav, D. M. , E. Varayil, J. Harmsen, W. Tremaine et al., A Population-based Study of Incidence, Risk Factors, Clinical Spectrum, and Outcomes of Ischemic Colitis, Clinical Gastroenterology and Hepatology, vol.13, issue.4, pp.731-739, 2015.
DOI : 10.1016/j.cgh.2014.07.061

A. Nationale-d, Accréditation et d'Evaluation en Santé. Indications for stool tests in adults, Gastroentérologie Clin Biol, vol.27, pp.627-669, 2003.

K. Becker, R. Snider, and E. Nylen, Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target, British Journal of Pharmacology, vol.6, issue.2, pp.253-64, 20101.
DOI : 10.1111/j.1476-5381.2009.00433.x

J. Whicher, J. Bienvenu, and G. Monneret, Procalcitonin as an Acute Phase Marker, Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine, vol.38, issue.5, pp.483-93, 2001.
DOI : 10.1177/000456320103800505

A. Luzzani, E. Polati, R. Dorizzi, A. Rungatscher, R. Pavan et al., Comparison of procalcitonin and C-reactive protein as markers of sepsis, Critical Care Medicine, vol.31, issue.6, pp.1737-1778, 2003.
DOI : 10.1097/01.CCM.0000063440.19188.ED

M. Assicot, D. Gendrel, H. Carsin, R. J. Guilbaud, J. Bohuon et al., High serum procalcitonin concentrations in patients with sepsis and infection Evaluation of potential biomarkers for the discrimination of bacterial and viral infections, Lancet. Infection, vol.34139, pp.515-523, 2011.

C. Wacker, A. Prkno, F. Brunkhorst, P. Schlattmann, K. Thia et al., Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis Role of procalcitonin in infectious gastroenteritis and inflammatory bowel disease, Lancet Infect Dis. Dig Dis Sci, vol.1353, pp.426-461, 2008.

K. Herrlinger, R. Dittmann, G. Weitz, J. Wehkamp, D. Ludwig et al., Serum Procalcitonin Differentiates Inflammatory Bowel Disease and Self-limited Colitis, Inflammatory Bowel Diseases, vol.10, issue.3, pp.229-262, 2004.
DOI : 10.1097/00054725-200405000-00008

C. Cosse, C. Sabbagh, F. Browet, F. Mauvais, L. Rebibo et al., Serum value of procalcitonin as a marker of intestinal damages: type, extension, and prognosis, Surgical Endoscopy, vol.17, issue.Suppl 1, pp.3132-3141, 2015.
DOI : 10.1007/s00464-014-4038-0

D. Gerding and F. Lessa, The Epidemiology of Clostridium difficile Infection Inside and Outside Health Care Institutions, Infectious Disease Clinics of North America, vol.29, issue.1, pp.37-50, 2015.
DOI : 10.1016/j.idc.2014.11.004

A. Baqui, R. Black, M. Yunus, A. Hoque, H. Chowdhury et al., Methodological Issues in Diarrhoeal Diseases Epidemiology: Definition of Diarrhoeal Episodes, International Journal of Epidemiology, vol.20, issue.4, pp.1057-63, 1991.
DOI : 10.1093/ije/20.4.1057

R. Thoeni and J. Cello, CT Imaging of Colitis, Radiology, vol.240, issue.3, pp.623-661, 2006.
DOI : 10.1148/radiol.2403050818

L. Beaugerie, Colites inclassées. Hépato-Gastro Oncol Dig, pp.677-86, 20151.

C. Favier, H. Bonneau, T. Minh, V. Devic, and J. , Endoscopic diagnosis of regressive ischemic colitis. Endoscopic, histologic and arteriographic correlations]. Nouv Presse Médicale, pp.77-86, 197610.

R. Colin, J. Balmes, and C. Favier, [Endoscopy in the diagnosis of regressive ischemic colitis], Chir Mém Académie Chir, vol.100, pp.49-51, 1974.

L. Marnell, C. Mold, D. Clos, and T. , C-reactive protein: Ligands, receptors and role in inflammation, Clinical Immunology, vol.117, issue.2, pp.104-115, 2005.
DOI : 10.1016/j.clim.2005.08.004

P. Lochhead, H. Khalili, A. Ananthakrishnan, J. Richter, A. Chan et al., Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease Korczowski B, Szybist W. Serum procalcitonin and C-reactive protein in children with diarrhoea of various aetiologies The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. Acta Paediatr Oslo Nor J Infect, vol.149360, pp.818-842, 1992.

L. Beaugerie, Épidémiologie des diarrhées et colites aiguës infectieuses en France, Lett Hépato-Gastroentérologue, vol.1, pp.13-16, 2001.

C. Surawicz, R. Haggitt, M. Husseman, and L. Mcfarland, Mucosal biopsy diagnosis of colitis: Acute self-limited colitis and idiopathic inflammatory bowel disease, Gastroenterology, vol.107, issue.3, pp.755-63, 1994.
DOI : 10.1016/0016-5085(94)90124-4

B. Notteghem, J. Salomez, C. Gower-rousseau, R. Marti, M. Lemahieu et al., What is the prognosis in unclassified colitis? Results of a cohort study of 104 patients in the Northern-Pas-de-Calais region, Gastroentérologie Clin Biol, vol.17, pp.811-816, 1993.

F. Tedesco, R. Hardin, R. Harper, and B. Edwards, Infectious colitis endoscopically simulating inflammatory bowel disease: a prospective evaluation, Gastrointestinal Endoscopy, vol.29, issue.3, pp.195-202, 1983.
DOI : 10.1016/S0016-5107(83)72583-6

G. Schumacher, B. Sandstedt, and B. Kollberg, A Prospective Study of First Attacks of Inflammatory Bowel Disease and Infectious Colitis: Clinical Findings and Early Diagnosis, Scandinavian Journal of Gastroenterology, vol.29, issue.3, pp.265-74, 1994.
DOI : 10.3109/00365529409090475

S. Yadav, D. M. , E. Varayil, J. Harmsen, W. Tremaine et al., A Population-based Study of Incidence, Risk Factors, Clinical Spectrum, and Outcomes of Ischemic Colitis, Clinical Gastroenterology and Hepatology, vol.13, issue.4, pp.731-739, 2015.
DOI : 10.1016/j.cgh.2014.07.061

A. Nationale-d, Accréditation et d'Evaluation en Santé. Indications for stool tests in adults, Gastroentérologie Clin Biol, vol.27, pp.627-669, 2003.

K. Becker, R. Snider, and E. Nylen, Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target, British Journal of Pharmacology, vol.6, issue.2, pp.253-64, 20101.
DOI : 10.1586/14787210.6.6.867

J. Whicher, J. Bienvenu, and G. Monneret, Procalcitonin as an Acute Phase Marker, Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine, vol.38, issue.5, pp.483-93, 2001.
DOI : 10.1177/000456320103800505

A. Luzzani, E. Polati, R. Dorizzi, A. Rungatscher, R. Pavan et al., Comparison of procalcitonin and C-reactive protein as markers of sepsis, Critical Care Medicine, vol.31, issue.6, pp.1737-1778, 2003.
DOI : 10.1097/01.CCM.0000063440.19188.ED

M. Assicot, D. Gendrel, H. Carsin, R. J. Guilbaud, J. Bohuon et al., High serum procalcitonin concentrations in patients with sepsis and infection Evaluation of potential biomarkers for the discrimination of bacterial and viral infections, Lancet. Infection, vol.34139, pp.515-523, 2011.

C. Wacker, A. Prkno, F. Brunkhorst, P. Schlattmann, K. Thia et al., Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis Role of procalcitonin in infectious gastroenteritis and inflammatory bowel disease, Lancet Infect Dis. Dig Dis Sci, vol.1353, pp.426-461, 2008.

K. Herrlinger, R. Dittmann, G. Weitz, J. Wehkamp, D. Ludwig et al., Serum Procalcitonin Differentiates Inflammatory Bowel Disease and Self-limited Colitis, Inflammatory Bowel Diseases, vol.10, issue.3, pp.229-262, 2004.
DOI : 10.1097/00054725-200405000-00008

C. Cosse, C. Sabbagh, F. Browet, F. Mauvais, L. Rebibo et al., Serum value of procalcitonin as a marker of intestinal damages: type, extension, and prognosis, Surgical Endoscopy, vol.17, issue.Suppl 1, pp.3132-3141, 2015.
DOI : 10.5505/tjtes.2011.70493

D. Gerding and F. Lessa, The Epidemiology of Clostridium difficile Infection Inside and Outside Health Care Institutions, Infectious Disease Clinics of North America, vol.29, issue.1, pp.37-50, 2015.
DOI : 10.1016/j.idc.2014.11.004

A. Baqui, R. Black, M. Yunus, A. Hoque, H. Chowdhury et al., Methodological Issues in Diarrhoeal Diseases Epidemiology: Definition of Diarrhoeal Episodes, International Journal of Epidemiology, vol.20, issue.4, pp.1057-63, 1991.
DOI : 10.1093/ije/20.4.1057

R. Thoeni and J. Cello, CT Imaging of Colitis, Radiology, vol.240, issue.3, pp.623-661, 2006.
DOI : 10.1148/radiol.2403050818

L. Beaugerie, Colites inclassées. Hépato-Gastro Oncol Dig, pp.677-86, 20151.

C. Favier, H. Bonneau, T. Minh, V. Devic, and J. , Endoscopic diagnosis of regressive ischemic colitis. Endoscopic, histologic and arteriographic correlations]. Nouv Presse Médicale, pp.77-86, 197610.

R. Colin, J. Balmes, and C. Favier, [Endoscopy in the diagnosis of regressive ischemic colitis], Chir Mém Académie Chir, vol.100, pp.49-51, 1974.

L. Marnell, C. Mold, D. Clos, and T. , C-reactive protein: Ligands, receptors and role in inflammation, Clinical Immunology, vol.117, issue.2, pp.104-115, 2005.
DOI : 10.1016/j.clim.2005.08.004

P. Lochhead, H. Khalili, A. Ananthakrishnan, J. Richter, A. Chan et al., Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease Korczowski B, Szybist W. Serum procalcitonin and C-reactive protein in children with diarrhoea of various aetiologies The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. Acta Paediatr Oslo Nor J Infect, vol.149360, pp.818-842, 1992.